Noonan Syndrome

Noonan Syndrome is a genetic condition that affects how the body grows and develops. It can cause short stature, a webbed neck, and heart problems. It also affects the face, skin, and sometimes intelligence. It's caused by changes in certain genes.

ConditionRare Disease

What people with Noonan Syndrome report

Every report comes from a Lived member, sent anonymously.

Have you tried Human Growth Hormone (HGH) for Noonan Syndrome?

NameHow it went

About Noonan Syndrome

What It Is

Noonan syndrome is a genetic condition, present from birth, that affects how many parts of the body develop. Its most recognizable features are a heart problem present at birth, shorter-than-average height and a particular set of facial features, such as widely spaced eyes, drooping eyelids and low-set ears that are rotated backward. Many people also have a short neck with extra skin folds (webbing), an unusually shaped chest, a tendency to bruise or bleed easily, and eye or hearing problems. The condition varies widely, even between a parent and child who share it. Some babies need heart treatment early and children may need extra support at school, while other people have features so mild that they are recognized only as adults, sometimes after their own child is diagnosed. It is one of the more common genetic syndromes, affecting roughly 1 in 1,000 to 2,500 people. Older names such as male Turner syndrome reflect a surface resemblance to Turner syndrome, but that is a different condition that affects only girls and women, while Noonan syndrome affects both sexes.

Causes & Risk Factors

Noonan syndrome is caused by a change (variant) in one of several genes that control the RAS/MAPK pathway, a signaling system that tells cells when to grow and divide. Most of these changes leave part of the pathway switched on longer than it should be, which alters how the heart, skeleton, lymphatic system and other tissues develop. A gene called PTPN11 accounts for about half of cases, and SOS1, RAF1, RIT1 and several others account for most of the rest. The condition usually follows an autosomal dominant pattern, meaning one altered copy of the gene is enough. A parent with Noonan syndrome has a 50% chance of passing it to each child. Many people have a new change that neither parent carries, but an affected parent is found in 30% to 75% of families, often someone whose features were mild enough to go unnoticed. When neither parent is affected, the chance that a brother or sister also has it appears to be low, under 1%. Changes in one gene, LZTR1, can also be inherited in a recessive pattern, where a child receives a changed copy from each parent. The specific gene can shape what doctors watch for. Thickened heart muscle is more common with RAF1 changes and a narrowed pulmonary valve with PTPN11 changes, and certain PTPN11 and KRAS changes carry a higher risk of a blood disorder in early childhood. Noonan syndrome belongs to a family of related conditions called RASopathies, which also includes Costello syndrome, cardiofaciocutaneous syndrome and neurofibromatosis type 1.

How It's Diagnosed

Doctors often first suspect Noonan syndrome because of a heart defect or murmur found in a baby, slow growth in early childhood, or the combination of facial features, chest shape and neck findings. A clinical geneticist examines the person, reviews the family history and compares the findings with established clinical criteria. Genetic testing, usually a panel that checks many Noonan-related genes at once, can confirm the diagnosis and identify the gene involved. A negative result does not rule the condition out: about 20% of people with a clear clinical picture have no detectable change in the genes known today. A diagnosis is also the starting point for a set of baseline checks, because some problems cause no symptoms at first. These usually include an echocardiogram (an ultrasound of the heart), an electrocardiogram (ECG, a recording of the heart's electrical activity), assessment of growth and puberty, eye and hearing exams, a developmental assessment, and blood tests of clotting, such as a platelet count and standard clotting-time tests that measure how quickly blood forms a clot. Recognizing Noonan syndrome in adults can be harder because the facial features soften with age, although drooping eyelids and the shape of the ears often persist. When a child is diagnosed, doctors often suggest examining the parents too.

Treatment Options

There is no treatment that reverses the underlying gene change. Care focuses on finding and treating each feature early, usually coordinated among a pediatrician or primary care doctor, a cardiologist, an endocrinologist, a geneticist and other specialists as needed. Heart problems are generally treated as they would be in anyone else. Pulmonary valve stenosis, a narrowing of the valve that lets blood flow from the heart to the lungs, ranges from mild cases that are only watched to more severe ones that need a procedure to open or repair the valve. Hypertrophic cardiomyopathy, a thickening of the heart muscle, is followed closely by a cardiologist. For severe cardiomyopathy or serious lymphatic problems that do not respond to usual care, some specialists have used trametinib (Mekinist), a cancer medicine that dampens the overactive signaling pathway. A 2024 retrospective study linked it to fewer heart operations, transplants and deaths, but the evidence is still limited and this is not an FDA-approved use. Growth hormone injections can increase height. Somatropin, sold as Norditropin among other brands, is FDA approved for short stature associated with Noonan syndrome in children and is given as an injection under the skin six or seven days a week, usually for several years. In one long-term study, children who started treatment around age 11 to 12 reached an adult height about 9 to 11 centimeters (roughly 4 inches) taller than predicted. Studies have not shown that growth hormone raises tumor risk or worsens heart muscle thickening, but because both are concerns in Noonan syndrome, doctors usually confirm the diagnosis genetically first and monitor with regular checkups and heart ultrasounds. A bleeding tendency is managed by planning ahead: clotting tests before any surgery, and specific treatment guided by the exact clotting problem if serious bleeding occurs. Aspirin, which further weakens clotting, should be avoided. Developmental and learning differences are addressed through early intervention programs and individualized education plans. Feeding difficulties in infancy, undescended testes, misaligned eyes (strabismus) and hearing loss receive the same standard treatments as in other children.

What to Expect

The long-term outlook depends mostly on the heart. Apart from heart disease, few complications of Noonan syndrome are known to shorten life, and many adults need little specialized care day to day, since many features become milder with age. Babies often have feeding difficulties, with frequent vomiting and poor intake; many improve by about 18 months, although some need a feeding tube for a time. Many children have intelligence in the typical range, but learning, language and attention difficulties are more common, and up to a quarter have mild intellectual disability. Without growth hormone, adults are usually shorter than average, and puberty often starts late. Women generally have normal fertility, while some men have reduced fertility, partly because of undescended testes. Follow-up continues for life. Children have regular checks of growth, development, vision and hearing. Those with certain PTPN11 or KRAS changes may have an exam of the spleen and a blood count every 3 to 6 months until age 5, because of a higher risk of juvenile myelomonocytic leukemia (JMML), a rare blood cancer of early childhood. Overall, children with Noonan syndrome are estimated to have about eight times the usual risk of leukemia and some other childhood cancers, though these cancers remain uncommon. Heart checks continue into adulthood, at least every five years and more often for people with known heart disease, and guidelines stress a planned move from pediatric to adult care. For adults with Noonan syndrome, each child has a 50% chance of inheriting it. During pregnancy, a review by an adult congenital heart team is worth considering, along with a hematology referral for anyone with a history of bleeding problems.

When to Seek Help

Ask about an evaluation if a child has a heart defect along with slow growth, characteristic facial features or easy bruising, or if you recognize these features in yourself after a relative's diagnosis. Book a review with the care team if growth seems to stall, puberty seems late, or concerns about learning, hearing or vision come up. Contact the care team about unusual bruising, nosebleeds that are hard to stop, heavy menstrual periods or bleeding that lasts longer than expected after an injury. Also report new or persistent headaches, neck pain, dizziness, changes in muscle tone or loud snoring with pauses in breathing, which can point to a problem at the base of the skull that is sometimes seen with the condition. Before any surgery, make sure the surgical team knows about the diagnosis so clotting can be checked. Contact the heart team promptly about fainting, chest pain or a racing or irregular heartbeat. In people with thickened heart muscle, fainting is a recognized warning sign for a dangerous heart rhythm.

Questions to Ask Your Doctor

  1. 1.Which gene change was found, and does it change what we should watch for, such as heart muscle disease or blood disorders in early childhood?
  2. 2.How significant is the heart finding, and how often will heart checks be needed now and in adulthood?
  3. 3.Would growth hormone treatment be worthwhile, and what monitoring would it involve?
  4. 4.Should clotting tests be done before any surgery, and which pain relievers should we avoid?
  5. 5.Should other family members be evaluated, and what are the chances for future children?

Last reviewed • Oct 2026

Educational content, not medical advice.